High-frequency ultrasound platform for preclinical imaging, supporting real-time visualization of small animal anatomy and ...
Vensica Medical receives US FDA IND clearance to begin phase 2 study of ViXe; a needle-free Xeomin delivery system for overactive bladder: New York Thursday, April 30, 2026, 17:00 ...
Vensica Medical, a clinical-stage company developing needle-free therapeutic delivery solutions for urologic diseases, today ...
Flow Space on MSN
Overactive bladder symptoms in women: Signs you shouldn't ignore
These everyday bladder habits can feel normal. That doesn't mean they are.
Imagine losing your bladder control, vision and muscle strength. Your breathing, swallowing and ability to say words and move ...
Don’t wait to start.
TheNewswire - BioVaxys Technology Corp. (CSE: BIOV OTCQB:BVAXF FRA:5LB0), a clinical-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today ...
Now, a new scan technique may help spot the condition earlier, a pilot study at Oxford University suggests. The technique ...
Learn how to take care of your prostate in your 30s, 40s and beyond, including symptoms to watch for and ways to reduce your ...
GLP-1 drugs are reshaping the lives of many, but such treatments can come with a side order of stigma, even shame ...
Back pain can keep you from living life to the fullest, which is why prevention matters. If it strikes, you don’t have to ...
Detailed price information for Biovaxys Technology Corp (BIOV-CN) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results